Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 5296 AL 5310

Effects on transthyretin in plasma and cerebrospinal fluid by DHA-rich n - 3 fatty acid supplementation in patients with Alzheimer's disease: the OmegAD study

Faxén-Irving G, Freund-Levi Y, Eriksdotter-Jönhagen M, Basun H, Hjorth E, Palmblad J, Vedin I, Cederholm T, Wahlund LO.

J Alzheimers Dis. 2013;36(1):1-6. doi: 10.3233/JAD-121828.

Bapineuzumab and solanezumab for Alzheimer's disease: is the 'amyloid cascade hypothesis' still alive?

Tayeb HO, Murray ED, Price BH, Tarazi FI.

Expert Opin Biol Ther. 2013 Jul;13(7):1075-84. doi: 10.1517/14712598.2013.789856. Epub 2013 Apr 10.

Effects of SolCos model-based individual reminiscence on older adults with mild to moderate dementia due to Alzheimer disease: a pilot study

Van Bogaert P, Van Grinsven R, Tolson D, Wouters K, Engelborghs S, Van der Mussele S.

J Am Med Dir Assoc. 2013 Jul;14(7):528.e9-13. doi: 10.1016/j.jamda.2013.01.020. Epub 2013 Apr 9.

Vitamin E and memantine in Alzheimer's disease: clinical trial methods and baseline data

Dysken MW, Guarino PD, Vertrees JE, Asthana S, Sano M, Llorente M, Pallaki M, Love S, Schellenberg GD, McCarten JR, Malphurs J, Prieto S, Chen P, Loreck DJ, Carney S, Trapp G, Bakshi RS, Mintzer JE, Heidebrink JL, Vidal-Cardona A, Arroyo LM, Cruz AR, Kowall NW, Chopra MP, Craft S, Thielke S, Turvey CL, Woodman C, Monnell KA, Gordon K, Tomaska J, Vatassery G.

Alzheimers Dement. 2014 Jan;10(1):36-44. doi: 10.1016/j.jalz.2013.01.014. Epub 2013 Apr 11.

The multifunctional anti-inflammatory drugs used in the therapy of Alzheimer's disease

Shi S, Wang Z, Qiao Z.

Curr Med Chem. 2013;20(20):2583-8. doi: 10.2174/0929867311320200006.

New pharmacological approaches to the cholinergic system: an overview on muscarinic receptor ligands and cholinesterase inhibitors

Greig NH, Reale M, Tata AM.

Recent Pat CNS Drug Discov. 2013 Aug;8(2):123-41. doi: 10.2174/1574889811308020003.

Concentration of donepezil to the cognitive response in Alzheimer disease

Yang YH, Chen CH, Chou MC, Li CH, Liu CK, Chen SH.

J Clin Psychopharmacol. 2013 Jun;33(3):351-5. doi: 10.1097/JCP.0b013e31828b5087.

Development and mechanism of γ-secretase modulators for Alzheimer's disease

Crump CJ, Johnson DS, Li YM.

Biochemistry. 2013 May 14;52(19):3197-216. doi: 10.1021/bi400377p. Epub 2013 May 2.

Impact of ambulatory physiotherapy on motor abilities of elderly subjects with Alzheimer's disease

Manckoundia P, Taroux M, Kubicki A, Mourey F.

Geriatr Gerontol Int. 2014 Jan;14(1):167-75. doi: 10.1111/ggi.12075. Epub 2013 Apr 25.

Targeted drug delivery across the blood brain barrier in Alzheimer's disease

Rocha S.

Curr Pharm Des. 2013;19(37):6635-46. doi: 10.2174/13816128113199990613.

Phase I study on the pharmacokinetics and tolerance of ZT-1, a prodrug of huperzine A, for the treatment of Alzheimer's disease

Jia JY, Zhao QH, Liu Y, Gui YZ, Liu GY, Zhu DY, Yu C, Hong Z.

Acta Pharmacol Sin. 2013 Jul;34(7):976-82. doi: 10.1038/aps.2013.7. Epub 2013 Apr 29.

Neuropeptides in Alzheimer's disease: from pathophysiological mechanisms to therapeutic opportunities

Van Dam D, Van Dijck A, Janssen L, De Deyn PP.

Curr Alzheimer Res. 2013 Jun;10(5):449-68. doi: 10.2174/1567205011310050001.

[Autumnal edition in the spring]

Meyer G.

Pflege Z. 2013 Apr;66(4):193.

Effectiveness and safety of memantine treatment for Alzheimer's disease

Yang Z, Zhou X, Zhang Q.

J Alzheimers Dis. 2013;36(3):445-58. doi: 10.3233/JAD-130395.

Adherence to cholinesterase inhibitors in Alzheimer's disease: a review

Brady R, Weinman J.

Dement Geriatr Cogn Disord. 2013;35(5-6):351-63. doi: 10.1159/000347140. Epub 2013 Apr 19.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias